Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Saturday, November 16, 2013

Leerink Swann Downgrades Cellular Dynamics International to Market Perform

They currently have a $15.00 target price on the stock. Leerink Swann's target price would suggest a potential upside of 1.42% from the company's current price.

http://www.americanbankingnews.com/2013/11/16/leerink-swann-downgrades-cellular-dynamics-international-to-market-perform-icel/

No comments:

Post a Comment

Popular Stem Cell Roundup Posts